US Inhaled Insulin Therapeutic Choice Questionnaire Study

Completed · Phase 3

Conditions studied: Diabetes Mellitus, Type 2

In brief

This is a questionnaire based study (no study drug is involved) that asks if more patients with uncontrolled type 2 diabetes on diabetes pills will choose insulin as the next treatment choice if inhaled insulin were available in addition to all currently available treatments, compared with if inhaled insulin was not available as part of currently available treatments. This study will also ask if patients with uncontrolled type 2 diabetes currently managed on diabetes pills + once daily insulin will choose as the next treatment choice to take insulin multiple times a day if inhaled insulin were available in addition to all currently available treatments, compared with if inhaled insulin was not available as part of currently available treatments.

Key facts

Study ID

NCT00139763

Run by

Pfizer

People needed

740

Starts

2005-07-01

Expected to finish

2006-03-01

Last updated by the study team

2007-03-19

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female, age > = 18 years and <= 80 years with a diagnosis of type 2 diabetes made at least 6 months prior to study entry
• Currently treated with either:
• 2 or more oral antidiabetic agents, OR 1 or more oral antidiabetic agents and insulin glargine

You may not qualify if…

• Type 1 diabetes
• Smoking within the past 6 months

Where it is running

• Pfizer Investigational Site — Chandler, Arizona, United States
• Pfizer Investigational Site — Mesa, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Tempe, Arizona, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Colorado Springs, Colorado, United States
• Pfizer Investigational Site — Newark, Delaware, United States
• Pfizer Investigational Site — Wilmington, Delaware, United States
• Pfizer Investigational Site — Washington D.C., District of Columbia, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Hayden, Idaho, United States
• Pfizer Investigational Site — Nampa, Idaho, United States
• Pfizer Investigational Site — Gurnee, Illinois, United States
• Pfizer Investigational Site — Elkton, Maryland, United States
• Pfizer Investigational Site — Detroit, Michigan, United States
• Pfizer Investigational Site — Minneapolis, Minnesota, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — Omaha, Nebraska, United States
• Pfizer Investigational Site — Margate City, New Jersey, United States
• Pfizer Investigational Site — Santa Fe, New Mexico, United States
• Pfizer Investigational Site — New York, New York, United States
• Pfizer Investigational Site — Morehead City, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.